EXPRES2ION BIOTECHNOLOGIES ApS: Financial statements 2013
CVR: 32770487
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
EXPRES2ION BIOTECHNOLOGIES ApS (CVR 32770487) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 5,661,707 and a net result of DKK 584,999 compared with DKK -1,779,867 the year before. That is an increase of 250.2% compared with the year before. Equity in the 2013 report amounted to DKK 1,611,170. The solvency ratio was 47%.
- Gross Profit
- DKK 5,661,707
- Profit/Loss
- DKK 584,999
- Equity
- DKK 1,611,170
- Total Assets
- DKK 3,426,449
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
EXPRES2ION BIOTECHNOLOGIES ApS has published its annual report for 2012. Gross profit came to DKK 1,616,505, and the net result was DKK -1,779,867.
As of May 21, 2013, Alexander R Duncan has joined the board of directors of EXPRES2ION BIOTECHNOLOGIES ApS.
As of May 21, 2013, Martin Welschof has left the board of directors of EXPRES2ION BIOTECHNOLOGIES ApS.
About EXPRES2ION BIOTECHNOLOGIES ApS
EXPRES2ION BIOTECHNOLOGIES ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ApS KBURS 17 NR. 6965. The management consists of Bent Ulrich Frandsen. The board consists of Martin Roland Jensen (chair), Jakob Ole Knudsen, Karin Garre and Michel Jean Baijot. The company is owned by Expres2ion Biotech Holding AB. The company has 19 employees (2026). In 2025, the company reported a gross profit of DKK -9,158,236 and a net result of DKK -21,948,253 compared with DKK -19,830,535 the year before. Equity in the 2025 report amounted to DKK 23,950,262.